Rosetta Genomics Ltd.(Other OTC/NBB : ROSG)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.22%||69.52||1.0%||$508.69m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.71%||202.99||1.9%||$475.58m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.10%||627.01||2.7%||$468.81m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.57%||4.17||0.7%||$291.50m|
|EXAS||EXACT Sciences Corp.||-5.37%||76.24||18.0%||$147.67m|
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.